Maximus (NYSE:MMS) Downgraded to “Strong Sell” Rating by Zacks Research

Zacks Research cut shares of Maximus (NYSE:MMS) from a hold rating to a strong sell rating in a report issued on Tuesday,Zacks.com reports.

A number of other research analysts have also weighed in on the company. Weiss Ratings lowered Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Wall Street Zen cut Maximus from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Reduce”.

Maximus Price Performance

Shares of MMS opened at $54.45 on Tuesday. The stock has a market cap of $2.85 billion, a PE ratio of 8.04 and a beta of 0.59. The company has a debt-to-equity ratio of 0.90, a quick ratio of 2.42 and a current ratio of 2.42. Maximus has a fifty-two week low of $52.73 and a fifty-two week high of $100.00. The firm’s 50-day simple moving average is $58.24 and its two-hundred day simple moving average is $66.33.

Maximus (NYSE:MMS) last released its earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.21 by $0.01. Maximus had a net margin of 7.07% and a return on equity of 24.91%. The firm had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.33 billion. During the same period last year, the business earned $2.16 earnings per share. The business’s revenue was down 5.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. Analysts anticipate that Maximus will post 8.01 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be issued a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 2.4%. The ex-dividend date is Friday, August 14th. Maximus’s dividend payout ratio (DPR) is presently 19.50%.

Hedge Funds Weigh In On Maximus

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Royal Bank of Canada increased its position in Maximus by 146.2% during the first quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider’s stock valued at $1,345,000 after acquiring an additional 11,716 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Maximus by 0.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock valued at $2,351,000 after purchasing an additional 221 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Maximus by 7.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider’s stock valued at $12,321,000 after purchasing an additional 11,754 shares during the last quarter. Jane Street Group LLC increased its position in shares of Maximus by 941.2% during the 1st quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider’s stock valued at $6,701,000 after purchasing an additional 88,835 shares during the last quarter. Finally, Sivia Capital Partners LLC purchased a new stake in shares of Maximus during the 2nd quarter valued at about $204,000. Institutional investors own 97.21% of the company’s stock.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.